Bonumose, Inc.
PrivateLast Round
Series C
Jul 6, 2023
Total Funding Raised
$70.82M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Bonumose, Inc. operates in Healthcare & Life Sciences and is based in Charlottesville, Virginia. Its latest recorded funding round was a Series C round in July 2023.
Bonumose, Inc. is an agriculture & food tech company that produces healthy sugar alternatives by using a patented enzymatic process to convert plant-based starches into rare sugars like tagatose and allulose.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Circular Economy, Clean Manufacturing
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bonumose, Inc. Comparables
Compare Bonumose, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Icon Foods | 78% | |
| Ambrosia Bio | 77% | |
| Resugar | 76% |
For institutional investors. Book with your work email.
Bonumose, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jul 6, 2023 | ||||
| Series B Extension | Dec 10, 2021 | ||||
| Grant | Oct 14, 2021 | ||||
| Series B | Feb 17, 2021 | ||||
| Strategic | Sep 4, 2020 | ||||
Debt | Apr 28, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Bonumose, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| iSelect Fund | Series B, Series B Extension, Series C, Series A |
| NextGen Nutrition Investment Partners | Series B Extension |
| Argonautic Ventures | Series B, Series C, Series A |
| Virginia Investment Performance Program | Grant |
| Hershey | Series B Extension, Series B |
| Lagomaj Capital | Series C |
| Cure8 Ventures | Series B, Series C, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 53% MoM.
- Apr 23, 2026
Monthly visitors increased 59% MoM, reaching 2.4K.
For institutional investors. Book with your work email.
Bonumose, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Bonumose, Inc.'s valuation, stock price, and market status.
Is Bonumose, Inc. a public or private company?
Bonumose, Inc. is a private company.
What is the current stock price of Bonumose, Inc.?
Bonumose, Inc. is a private company, so its shares have no public market price. Caplight tracks Bonumose, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Bonumose, Inc. worth (valuation)?
Valuation information for Bonumose, Inc. is not publicly available.
Can I buy Bonumose, Inc. stock?
Bonumose, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Bonumose, Inc.'s last funding round?
Bonumose, Inc.'s most recent funding round was Series C on July 6, 2023.
Who are the main investors in Bonumose, Inc.?
Key investors in Bonumose, Inc. include Hershey.
Will Bonumose, Inc. IPO soon?
No public IPO plans have been announced for Bonumose, Inc..
How can I track Bonumose, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Bonumose, Inc.'s shares on secondary markets.